Group 1 - The core viewpoint of the news is the performance and holdings of the Huatai-PineBridge Medical Active Growth One-Year Holding Mixed Fund A, which has shown varying returns over different time frames [1] - As of May 23, 2025, the fund's latest net value is 0.6165 yuan, reflecting a decrease of 0.68% [1] - The fund's performance over the past month has yielded a return of 3.44%, ranking 1122 out of 4670 in its category [1] - Over the past six months, the fund has achieved a return of 19.41%, ranking 278 out of 4504 [1] - Year-to-date, the fund has returned 24.29%, ranking 139 out of 4554 [1] Group 2 - The top ten stock holdings of the fund account for a total of 56.30%, with the largest holding being Kelun-Botai at 9.63% [1] - Other significant holdings include BeiGene-U (8.84%), Kangfang Biotech (7.07%), and Betta Pharmaceuticals (5.98%) [1] - The fund was established on August 21, 2020, and as of March 31, 2025, it has a total scale of 1.68 billion yuan [1] - The fund manager is Zheng Lei, who has extensive experience in the medical and healthcare investment sector [2]
5月23日汇添富医疗积极成长一年持有混合A净值下跌0.68%，近1个月累计上涨3.44%
Sou Hu Cai Jing·2025-05-23 13:50